Atlas Trials

Evaluation of Romosozumab vs. Zoledronic Acid Effect in Patients With Spinal Cord Injury and Low Bone Mineral Density

Clinical trial NCT04597931 · UNKNOWN

Trial details

NCT number
NCT04597931
Sponsor
Sheba Medical Center
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Osteoporosis FractureSpinal Cord Injuries
Start date
2020-11-01
Primary completion
2023-11-15
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.